Sánchez MJ, Partida GA, Perezpeña DM, Flores AEM, Olivar LV, Gomezchico VR, Farfán QR, Chávez LA

Idioma: Español
Referencias bibliográficas: 29
Paginas: 385-396
Archivo PDF: 499.31 Kb.

FRAGMENTO

RESUMEN DE LA HISTORIA CLÍNICA (A-07-31)

Se trata de un paciente masculino de 3 meses que ingresa con irritabilidad, llanto, hiporexia y vómito; se presentaron convulsiones tónico-clónicas en cuatro ocasiones. También presentó acidosis metabólica y requirió asistencia ventilatoria.

REFERENCIAS (EN ESTE ARTÍCULO)

1. American Academy of Pediatrics, American Heart Association. Pediatric Advanced Life Support Provider Manual. U.S.: AHA; 2006. pp. 1-43.

2. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroides para la meningitis bacteriana aguda (Revisión Cochrane traducida). En: La Colaboración Cochrane. Revisiones Cochrane 2008;4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com.

3. Warren J, Fromm RE Jr, Orr RA, Rotello LC, Horst HM; American College of Critical Care Medicine. Guidelines for the inter- and intrahospital transport of critically ill patients. Crit Care Med 2004;32:256-262.

4. Orr RA, Felmet KA, Han Y, McCloskey KA, Dragotta MA, Bills DM, et al. Pediatric specialized transport teams are associated with improved outcomes. Pediatrics 2009;124:40-48.

5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knolich B, et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001;345:1368-1377.

6. Carcillo JA, Fields A; American College of Critical Care Medicine Task Force Committee Members. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30:1365-1378.

7. Dellinger J, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.

8. Mikkelsen ME, Gaieski DF, Goyal M, Miltiades A, Munson JC, Pines JM, et al. Factors associated with nonadherence to early goal-directed therapy in the emergency department. Chest 2010;138:551-558.

9. Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Pediatric Index of Mortality. Intensive Care Med 2003;29:278-285.

10. Pizarro CF, Troster EJ, Damiani D, Carcillo JA. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 2005;33:855-859.

11. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Eng J Med 2001;345:588-595.

12. Hollenberg SM. Vasopressor support in septic shock. Chest 2007;132:1678-1687.

13. Abdel-Aziz M, El-Hoshy H. Acute mastoiditis: A one year study in the pediatric hospital of Cairo university. BMC Ear Nose Throat Disord 2010;10:1-6.

14. Gliklich RE, Eavey RD, Iannuzzi RA, Camacho AR. A contemporary analysis of acute mastoiditis. Arch Otolaryngol Head Neck Surg 1996;122:135-139.

15. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007;35:1105-1112.

16. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596.

17. American Academy of Pediatrics. Haemophilus influenzae infections. En: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infec tious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. pp. 310-318.

18. Feigin RD, McCracken GH Jr. Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J 1992;11:785-814.

19. Paris MM, Ramilo O, McCracken GH Jr. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995;39:2171-2175.

20. Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother 1997;41:1888-1891.

21. Ninis N, Philips C, Bailey L, Pollok J, Nadel S, Britto J, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 2005;330:1475-1478.

22. Launay E, Gras-Le Guen C, Martinot A, Assathiany R, Blanchais T, Mourdi N, et al. Suboptimal care in the initial management of children who died from severe bacterial infection: a population-based confidential inquiry. Pediatr Crit Care Med 2010;11:469-474.

23. De Oliveira CF, De Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura AC, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparision with and without monitoring central venous oxygen saturation. Intensive Care Med 2008;34:1065-1075.

24. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-1465.

25. Rovers MM, Glasziou P, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 2006;368:1429-1435.

26. Dowell SF, Butler JC, Giebink GS, Jacobs MK, Jernigan D, Musher DM, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.

27. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1997;16:710-711.

28. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA 2003;290:1633-1640.

29. Pelton SI. Otoscopy for the diagnosis of otitis media. Pediatr Infect Dis J 1998;17:540-543.